Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 892

    1.

    Evolution of SIV toward RANTES resistance in macaques rapidly progressing to AIDS upon coinfection with HHV-6A.

    Biancotto A, Grivel JC, Lisco A, Vanpouille C, Markham PD, Gallo RC, Margolis LB, Lusso P.

    Retrovirology. 2009 Jul 2;6:61.PMID: 19573243 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Rapamycin enhances aplaviroc anti-HIV activity: implications for the clinical development of novel CCR5 antagonists.

    Latinovic O, Heredia A, Gallo RC, Reitz M, Le N, Redfield RR.

    Antiviral Res. 2009 Jul;83(1):86-9. Epub 2009 Mar 9.PMID: 19501260 [PubMed - indexed for MEDLINE]Related articles

    3.

    IFNalpha kinoid vaccine-induced neutralizing antibodies prevent clinical manifestations in a lupus flare murine model.

    Zagury D, Le Buanec H, Mathian A, Larcier P, Burnett R, Amoura Z, Emilie D, Peltre G, Bensussan A, Bizzini B, Gallo RC, Koutouzov S.

    Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5294-9. Epub 2009 Mar 11.PMID: 19279210 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infection.

    Guan Y, Sajadi MM, Kamin-Lewis R, Fouts TR, Dimitrov A, Zhang Z, Redfield RR, DeVico AL, Gallo RC, Lewis GK.

    Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3952-7. Epub 2009 Feb 18.PMID: 19225108 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Reduction of CCR5 with low-dose rapamycin enhances the antiviral activity of vicriviroc against both sensitive and drug-resistant HIV-1.

    Heredia A, Latinovic O, Gallo RC, Melikyan G, Reitz M, Le N, Redfield RR.

    Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20476-81. Epub 2008 Dec 15.PMID: 19075241 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Th2 polarization in peripheral blood mononuclear cells from human immunodeficiency virus (HIV)-infected subjects, as activated by HIV virus-like particles.

    Buonaguro L, Tornesello ML, Gallo RC, Marincola FM, Lewis GK, Buonaguro FM.

    J Virol. 2009 Jan;83(1):304-13. Epub 2008 Oct 22.PMID: 18945779 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Increased interferon alpha expression in circulating plasmacytoid dendritic cells of HIV-1-infected patients.

    Lehmann C, Harper JM, Taubert D, Hartmann P, Fätkenheuer G, Jung N, van Lunzen J, Stellbrink HJ, Gallo RC, Romerio F.

    J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):522-30.PMID: 18645522 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Kinoids: a novel generation of specific immune therapy against cytokines]

    Bensussan A, Bizzini B, Pouletty P, Gallo RC, Zagury D.

    Med Sci (Paris). 2008 Mar;24(3):306-13. Review. French. PMID: 18334181 [PubMed - indexed for MEDLINE]Related articles

    9.

    Antibodies to CD4-induced sites in HIV gp120 correlate with the control of SHIV challenge in macaques vaccinated with subunit immunogens.

    DeVico A, Fouts T, Lewis GK, Gallo RC, Godfrey K, Charurat M, Harris I, Galmin L, Pal R.

    Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17477-82. Epub 2007 Oct 23.PMID: 17956985 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Functional and morphologic characterization of human T cells continuously grown in vitro. J. Immunol. 1977. 119: 131-138.

    Ruscetti FW, Morgan DA, Gallo RC.

    J Immunol. 2007 Aug 1;179(3):1415-22. No abstract available. PMID: 17641005 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    CCR5 density levels on primary CD4 T cells impact the replication and Enfuvirtide susceptibility of R5 HIV-1.

    Heredia A, Gilliam B, DeVico A, Le N, Bamba D, Flinko R, Lewis G, Gallo RC, Redfield RR.

    AIDS. 2007 Jun 19;21(10):1317-22.PMID: 17545708 [PubMed - indexed for MEDLINE]Related articles

    12.

    Rapamycin reduces CCR5 density levels on CD4 T cells, and this effect results in potentiation of enfuvirtide (T-20) against R5 strains of human immunodeficiency virus type 1 in vitro.

    Heredia A, Gilliam B, Latinovic O, Le N, Bamba D, Devico A, Melikyan GB, Gallo RC, Redfield RR.

    Antimicrob Agents Chemother. 2007 Jul;51(7):2489-96. Epub 2007 May 7.PMID: 17485501 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Human herpesvirus 6A accelerates AIDS progression in macaques.

    Lusso P, Crowley RW, Malnati MS, Di Serio C, Ponzoni M, Biancotto A, Markham PD, Gallo RC.

    Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5067-72. Epub 2007 Mar 14.PMID: 17360322 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    VEGF kinoid vaccine, a therapeutic approach against tumor angiogenesis and metastases.

    Rad FH, Le Buanec H, Paturance S, Larcier P, Genne P, Ryffel B, Bensussan A, Bizzini B, Gallo RC, Zagury D, Uzan G.

    Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2837-42. Epub 2007 Feb 14.PMID: 17301234 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    A perspective on human herpes virus 6 (HHV-6).

    Gallo RC.

    J Clin Virol. 2006 Dec;37 Suppl 1:S2. No abstract available. PMID: 17276365 [PubMed - indexed for MEDLINE]Related articles

    16.

    A plea for justice for jailed medical workers.

    Ahuja SK, Aiuti F, Berkhout B, Biberfeld P, Burton DR, Colizzi V, Deeks SG, Desrosiers RC, Dierich MP, Doms RW, Emerman M, Gallo RC, Girard M, Greene WC, Hoxie JA, Hunter E, Klein G, Korber B, Kuritzkes DR, Lederman MM, Malim MH, Marx PA, McCune JM, McMichael A, Miller C, Miller V, Montagnier L, Montefiori DC, Moore JP, Nixon DF, Overbaugh J, Pauza CD, Richman DD, Saag MS, Sattentau Q, Schooley RT, Shattock R, Shaw GM, Stevenson M, Trkola A, Wainberg MA, Weiss RA, Wolinsky S, Zack JA.

    Science. 2006 Nov 10;314(5801):924-5. Epub 2006 Oct 24. No abstract available. PMID: 17062652 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    A reflection on HIV/AIDS research after 25 years.

    Gallo RC.

    Retrovirology. 2006 Oct 20;3:72.PMID: 17054781 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses.

    Buonaguro L, Tornesello ML, Tagliamonte M, Gallo RC, Wang LX, Kamin-Lewis R, Abdelwahab S, Lewis GK, Buonaguro FM.

    J Virol. 2006 Sep;80(18):9134-43.PMID: 16940524 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    HIV-1 transgenic rat CD4+ T cells develop decreased CD28 responsiveness and suboptimal Lck tyrosine dephosphorylation following activation.

    Yadav A, Pati S, Nyugen A, Barabitskaja O, Mondal P, Anderson M, Gallo RC, Huso DL, Reid W.

    Virology. 2006 Sep 30;353(2):357-65. Epub 2006 Jul 10.PMID: 16828835 [PubMed - indexed for MEDLINE]Related articles

    20.

    Preclinical evaluation of synthetic -2 RANTES as a candidate vaginal microbicide to target CCR5.

    Kish-Catalone TM, Lu W, Gallo RC, DeVico AL.

    Antimicrob Agents Chemother. 2006 Apr;50(4):1497-509.PMID: 16569870 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    International NeuroAIDS: prospects of HIV-1 associated neurological complications.

    Trujillo JR, Jaramillo-Rangel G, Ortega-Martinez M, Penalva de Oliveira AC, Vidal JE, Bryant J, Gallo RC.

    Cell Res. 2005 Nov-Dec;15(11-12):962-9. Review.PMID: 16354575 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Commentary on "Prevalence and evolution of drug resistance HIV-1 variants in Henan, China".

    Gilliam BL, Redfield RR, Zhao RY, Gallo RC.

    Cell Res. 2005 Nov-Dec;15(11-12):850-1. No abstract available. PMID: 16354558 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Commentary remarks on "HIV/AIDS in China".

    Gallo RC.

    Cell Res. 2005 Nov-Dec;15(11-12):823. No abstract available. PMID: 16354553 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    The end or the beginning of the drive to an HIV-preventive vaccine: a view from over 20 years.

    Gallo RC.

    Lancet. 2005 Nov 26;366(9500):1894-8. Epub 2005 Sep 28. No abstract available. PMID: 16310557 [PubMed - indexed for MEDLINE]Related articles

    25.

    Indirubin-3'-monoxime, a derivative of a Chinese antileukemia medicine, inhibits P-TEFb function and HIV-1 replication.

    Heredia A, Davis C, Bamba D, Le N, Gwarzo MY, Sadowska M, Gallo RC, Redfield RR.

    AIDS. 2005 Dec 2;19(18):2087-95.PMID: 16284457 [PubMed - indexed for MEDLINE]Related articles

    26.

    HIV/AIDS research after HAART.

    Gallo RC.

    Res Initiat Treat Action. 2005 Summer;11(1):39-41. No abstract available. PMID: 16208818 [PubMed - indexed for MEDLINE]Related articles

    27.

    Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy.

    Popovic M, Tenner-Racz K, Pelser C, Stellbrink HJ, van Lunzen J, Lewis G, Kalyanaraman VS, Gallo RC, Racz P.

    Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14807-12. Epub 2005 Sep 30.PMID: 16199516 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    History of the discoveries of the first human retroviruses: HTLV-1 and HTLV-2.

    Gallo RC.

    Oncogene. 2005 Sep 5;24(39):5926-30. Review.PMID: 16155599 [PubMed - indexed for MEDLINE]Related articles

    29.

    Non-toxic immunogens for therapeutic anticytokine vaccines.

    Zagury D, Le Buanec H, Bizzini B, Gallo RC.

    IDrugs. 2001 Oct;4(10):1161-6.PMID: 15957085 [PubMed]Related articles

    30.

    The discovery of the first human retrovirus: HTLV-1 and HTLV-2.

    Gallo RC.

    Retrovirology. 2005 Mar 2;2:17.PMID: 15743526 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Sequence variation within the dominant amino terminus epitope affects antibody binding and neutralization of human immunodeficiency virus type 1 Tat protein.

    Ruckwardt TJ, Tikhonov I, Berg S, Hatfield GS, Chandra A, Chandra P, Gilliam B, Redfield RR, Gallo RC, Pauza CD.

    J Virol. 2004 Dec;78(23):13190-6.PMID: 15542671 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Differential polarization of immune responses by co-administration of antigens with chemokines.

    Frauenschuh A, DeVico AL, Lim SP, Gallo RC, Garzino-Demo A.

    Vaccine. 2004 Dec 9;23(4):546-54.PMID: 15530704 [PubMed - indexed for MEDLINE]Related articles

    33.

    Total chemical synthesis of N-myristoylated HIV-1 matrix protein p17: structural and mechanistic implications of p17 myristoylation.

    Wu Z, Alexandratos J, Ericksen B, Lubkowski J, Gallo RC, Lu W.

    Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11587-92. Epub 2004 Jul 27.PMID: 15280532 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    HIV-1: a look back from 20 years.

    Gallo RC.

    DNA Cell Biol. 2004 Apr;23(4):191-2. No abstract available. PMID: 15142376 [PubMed - indexed for MEDLINE]Related articles

    35.

    A journey with T cells, primate/human retroviruses and other persisting human T-cell tropic viruses.

    Gallo RC.

    Rev Clin Exp Hematol. 2003 Dec;7(4):329-35.PMID: 15129646 [PubMed - indexed for MEDLINE]Related articles

    36.

    Control of HIV-1 infection by soluble factors of the immune response.

    DeVico AL, Gallo RC.

    Nat Rev Microbiol. 2004 May;2(5):401-13. Review. No abstract available. PMID: 15100693 [PubMed - indexed for MEDLINE]Related articles

    37.

    HIV-1 transgenic rats develop T cell abnormalities.

    Reid W, Abdelwahab S, Sadowska M, Huso D, Neal A, Ahearn A, Bryant J, Gallo RC, Lewis GK, Reitz M.

    Virology. 2004 Mar 30;321(1):111-9.PMID: 15033570 [PubMed - indexed for MEDLINE]Related articles

    38.

    Anti-cytokine Ab immune therapy: present status and perspectives.

    Zagury D, Gallo RC.

    Drug Discov Today. 2004 Jan 15;9(2):72-81. Review.PMID: 15012931 [PubMed - indexed for MEDLINE]Related articles

    39.

    Public health. A sound rationale needed for phase III HIV-1 vaccine trials.

    Burton DR, Desrosiers RC, Doms RW, Feinberg MB, Gallo RC, Hahn B, Hoxie JA, Hunter E, Korber B, Landay A, Lederman MM, Lieberman J, McCune JM, Moore JP, Nathanson N, Picker L, Richman D, Rinaldo C, Stevenson M, Watkins DI, Wolinsky SM, Zack JA.

    Science. 2004 Jan 16;303(5656):316. No abstract available. PMID: 14726576 [PubMed - indexed for MEDLINE]Related articles

    40.

    The discovery of HIV as the cause of AIDS.

    Gallo RC, Montagnier L.

    N Engl J Med. 2003 Dec 11;349(24):2283-5. No abstract available. PMID: 14668451 [PubMed - indexed for MEDLINE]Related articles

    41.

    HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses.

    Abdelwahab SF, Cocchi F, Bagley KC, Kamin-Lewis R, Gallo RC, DeVico A, Lewis GK.

    Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15006-10. Epub 2003 Dec 1.PMID: 14657379 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV beta-chemokines: an approach to suppress R5 strains of HIV-1.

    Heredia A, Amoroso A, Davis C, Le N, Reardon E, Dominique JK, Klingebiel E, Gallo RC, Redfield RR.

    Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10411-6. Epub 2003 Aug 12.PMID: 12915736 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Therapeutic vaccine to control stromal tumor-induced immunosuppression in human uterine cervixc cancer.

    Le Buanec H, Cohen L, Paturance S, Burny A, Gallo RC, Zagury D.

    Cell Mol Biol (Noisy-le-grand). 2003 Jun;49(4):667-71.PMID: 12899461 [PubMed - indexed for MEDLINE]Related articles

    44.

    HIV receptors on lymphocytes.

    Garzino-Demo A, Gallo RC.

    Curr Opin Hematol. 2003 Jul;10(4):279-83. Review.PMID: 12799533 [PubMed - indexed for MEDLINE]Related articles

    45.

    Active versus passive anti-cytokine antibody therapy against cytokine-associated chronic diseases.

    Zagury D, Le Buanec H, Bizzini B, Burny A, Lewis G, Gallo RC.

    Cytokine Growth Factor Rev. 2003 Apr;14(2):123-37. Review.PMID: 12651224 [PubMed - indexed for MEDLINE]Related articles

    46.

    Historical essay. Prospects for the future.

    Gallo RC, Montagnier L.

    Science. 2002 Nov 29;298(5599):1730-1. No abstract available. PMID: 12459577 [PubMed - indexed for MEDLINE]Related articles

    47.

    Historical essay. The early years of HIV/AIDS.

    Gallo RC.

    Science. 2002 Nov 29;298(5599):1728-30. No abstract available. PMID: 12459576 [PubMed - indexed for MEDLINE]Related articles

    48.

    Epilogue: a journey with blood cells and viruses.

    Gallo RC.

    J Hematother Stem Cell Res. 2002 Oct;11(5):849-57. No abstract available. PMID: 12427290 [PubMed - indexed for MEDLINE]Related articles

    49.

    Robert C. Gallo, M.D. [Interview by Vicki P Glaser]

    Gallo RC.

    J Hematother Stem Cell Res. 2002 Oct;11(5):751-7. No abstract available. PMID: 12427281 [PubMed - indexed for MEDLINE]Related articles

    50.

    Targeting Tat and IFN(alpha) as a therapeutic AIDS vaccine.

    Gallo RC, Burny A, Zagury D.

    DNA Cell Biol. 2002 Sep;21(9):611-8.PMID: 12396603 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...